New treatment possibility for some cancer patients

Larotrectinib is approved by NICE as an option for NTRK fusion-positive solid tumours Picture: iStock Essential facts Larotrectinib is one of a new breed of cancer drugs designed to target specific changes in the DNA of cancer cells, rather than where the disease is growing in the body. This means patients, including children, with various cancer types may benefit from its use. It is particularly useful for those patients at an advanced stage of cancer, when other options are limited or have been exhausted.

New Fox Chase Clinical Trial Could Help Men With Intermediate-Risk Prostate Cancer Avoid Radical Treatment - Physician Resources

Here are 10 new advances in the battle to beat cancer

Study finds some prostate cancer patients can delay aggressive treatment

Cancer and its treatment could impact survivors' ability to work, says national report

It's an Absolute Miracle: Battling a Deadly Blood Cancer, a New Jersey Woman Gets a Second Chance — Thanks to Precision Medicine

Terminal Cancer Treatment: Richard Scolyer Tests Immune Therapies on Himself - Bloomberg

TGen News & Press Releases : TGen-UArizona medical school study points to possible new treatment options for breast cancer patients

Opinion Cancer Drug Advancements Give New Hope to Metastatic Patients - The New York Times

FDA Updates Highlighting the Latest Cancer Treatments, Article

Targeted Cancer Therapy Shows Promise Combined With Cholesterol-Lowering Drug

Innovative approaches for cancer treatment: current perspectives and new challenges - ecancer

Hot chemo' offers new treatment option

Scientists find possible genetic key to why some lymphoma patients don't respond to treatment

Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship